<br>From: <b class="gmail_sendername">Ruggiero, Mrs. Ana Lucia (WDC)</b> <span dir="ltr"><<a href="mailto:ruglucia@paho.org">ruglucia@paho.org</a>></span><br><div class="gmail_quote">crossposted from: <a href="mailto:EQUIDAD@listserv.paho.org">EQUIDAD@listserv.paho.org</a><br>
<br><br>













<div lang="EN-US" link="blue" vlink="purple">

<div>

<p class="MsoNormal" style="margin-left:.5in"><b><font size="3" color="maroon" face="Arial"><span style="font-size:12.0pt;font-family:Arial;color:maroon;font-weight:bold">The World Medicines Situation Report 2011<br>
<br>
</span></font></b></p>

<p class="MsoNormal" style="margin-left:.5in"><b><font size="3" face="Arial"><span style="font-size:12.0pt;font-family:Arial;font-weight:bold">World Health Organization
WHO<br>
<br>
</span></font></b><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial"></span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">Available online at: <span><a href="http://bit.ly/e28TDq" target="_blank"><font color="black"><span style="color:windowtext">http://bit.ly/e28TDq</span></font></a></span><br>

<br>
</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">The third edition of the World
Medicines Situation Report brings together new data on 24 key topics relating
to pharmaceutical production and consumption, innovation, regulation and safety
- in one place. <br>
<br>
</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">Topics include selection,
procurement, supply management, rational use, financing and pricing.
Cross-cutting chapters cover household medicines use, access and human rights,
good governance, human resources and national medicines policies.<br>
<br>
</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">The chapters released in April 2011
are:</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><b><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial;font-weight:bold">Introduction</span></font></b></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">Background on past and present
efforts to document and improve sharing of information. <br>
<br>
</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><b><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial;font-weight:bold">Medicines Prices
Availability and Affordability</span></font></b></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">Features data and information from
surveys using WHO standard methodology. Poor medicine availability,
particularly in the public sector, is a key barrier to access to medicines. <br>
<br>
</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><b><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial;font-weight:bold">Rational Use of
Medicines</span></font></b></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">Describes the problem of irrational
use of medicines and the harmful consequences in terms of morbidity, mortality
and impact to health cost. This chapter looks at global data, and draws
attention to trends in developing and transitional countries, in both public
and private sectors. </span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">Rational Use of Medicines - annexes <br>
<br>
</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><b><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial;font-weight:bold">Traditional
Medicines: Global Situation Issues and Challenges </span></font></b></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">Describes the use of traditional
medicines, including herbal medicines, in every country around the world. The
global market in traditional medicines is increasing exponentially, although
regulatory status varies greatly between countries. <br>
<br>
</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><b><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial;font-weight:bold">Access to
Controlled Medicines</span></font></b></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">International drug treaties stress
that psychotropic and narcotic substances available must be available for
medical and scientific use, even if they are classified as controlled
medicines. <br>
<br>
</span></font></p>

<p class="MsoNormal" style="margin-left:.5in"><b><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial;font-weight:bold">Good Governance</span></font></b></p>

<p class="MsoNormal" style="margin-left:.5in"><font size="2" face="Arial"><span style="font-size:10.0pt;font-family:Arial">Reviews the findings of country
studies, highlighting weaknesses and strengths in pharmaceutical systems that
can help policy-makers better understand problems and identify solutions. <br>
<br>
</span></font></p>

<p class="MsoNormal" style="margin-right:0in;margin-bottom:12.0pt;margin-left:.5in"><b><font size="1" face="Arial"><span style="font-size:9.0pt;font-family:Arial;font-weight:bold"> </span></font></b></p></div></div></div>